[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK1957037T3 - Farmaceutisk præparat til nasal anvendelse af fentanyl - Google Patents

Farmaceutisk præparat til nasal anvendelse af fentanyl

Info

Publication number
DK1957037T3
DK1957037T3 DK01988082.2T DK01988082T DK1957037T3 DK 1957037 T3 DK1957037 T3 DK 1957037T3 DK 01988082 T DK01988082 T DK 01988082T DK 1957037 T3 DK1957037 T3 DK 1957037T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical preparation
fentanyl
nasal use
soluble
water
Prior art date
Application number
DK01988082.2T
Other languages
English (en)
Inventor
Norbert Kloecker
Original Assignee
Nasalis Pain Relief Internat G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nasalis Pain Relief Internat G filed Critical Nasalis Pain Relief Internat G
Application granted granted Critical
Publication of DK1957037T3 publication Critical patent/DK1957037T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK01988082.2T 2000-12-22 2001-12-27 Farmaceutisk præparat til nasal anvendelse af fentanyl DK1957037T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10064219A DE10064219B9 (de) 2000-12-22 2000-12-22 Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
PCT/EP2001/015344 WO2002051380A1 (de) 2000-12-22 2001-12-27 Neue pharmazeutische zusammensetzung von wasserlöslichen oder schwer wasserlöslichen wirkstoffen

Publications (1)

Publication Number Publication Date
DK1957037T3 true DK1957037T3 (da) 2010-07-19

Family

ID=7668409

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01988082.2T DK1957037T3 (da) 2000-12-22 2001-12-27 Farmaceutisk præparat til nasal anvendelse af fentanyl

Country Status (8)

Country Link
EP (1) EP1957037B1 (da)
AT (1) ATE464878T1 (da)
CY (1) CY1110906T1 (da)
DE (2) DE10064219B9 (da)
DK (1) DK1957037T3 (da)
ES (1) ES2344730T3 (da)
PT (1) PT1957037E (da)
WO (1) WO2002051380A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100346788C (zh) 2000-07-31 2007-11-07 尼科梅德丹麦有限公司 用于鼻内给药的芬太尼组合物
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
DE10306761B9 (de) * 2003-02-17 2004-12-23 Völkl, Klaus Peter, Dr. Verfahren zur Herstellung von sterilen pharmazeutischen Wirkstoffen
AU2004218876B2 (en) * 2003-03-11 2007-08-02 Arakis Ltd. Novel compositions containing fentanyl
FR2859105B1 (fr) * 2003-09-02 2006-01-20 Vegeflore Composition pour le traitement ou la prevention du ronflement
DE10356248A1 (de) * 2003-11-13 2005-06-23 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
GB0416397D0 (en) * 2004-07-22 2004-08-25 Glaxo Group Ltd Pharmaceutical formulations
CA2604952A1 (en) * 2005-04-14 2006-10-19 Jarrow Formulas, Inc. Dietary supplement formulations for improved delivery of coenzyme q10 and methods of administration
EP2106786A1 (de) * 2008-04-04 2009-10-07 Roewer, Norbert, Univ.-Prof. Dr. med. Pharmazeutische Zubereitung mit permethyliertem Cyclodextrin
DE102009001041A1 (de) * 2009-02-20 2010-08-26 Marien-Apotheke Fulda Ohg Notfallset zur Herstellung eines Arzneimittels zur nasalen Anwendung von Opioiden bei Atemnot
GB0904423D0 (en) * 2009-03-14 2009-04-29 Univ Strathclyde Improving the solubility of chemicals
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
JP6110367B2 (ja) 2011-05-13 2017-04-05 ユーロ−セルティーク エス．エイ． ナロキソンを含む鼻腔内医薬剤形
MY183615A (en) 2011-06-17 2021-03-03 Berg Llc Inhalable pharmaceutical compositions
US20210000910A1 (en) 2019-07-03 2021-01-07 Jysk Skin Solutions Pte Ltd Topical compositions
WO2023046590A1 (en) * 2021-09-22 2023-03-30 Jadran - Galenski Laboratorij D.D. An improved pharmaceutical composition for nasal use, preparation, and use thereof
US12083204B2 (en) 2022-06-02 2024-09-10 L'oreal Topical composition for homeostatic delivery of nitric oxide and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02213A (ja) * 1987-10-19 1990-01-05 Taiho Yakuhin Kogyo Kk 生理活性ペプチド持続製剤
ES2146200T3 (es) 1990-02-13 2000-08-01 Ethicon Inc Medicamentos inducidos peritonealmente.
JP2951681B2 (ja) * 1990-02-23 1999-09-20 株式会社資生堂 経粘膜投与用薬剤組成物
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
DE69227607T2 (de) * 1991-07-10 1999-04-15 Takeda Chemical Industries, Ltd., Osaka Arzneimittel auf Basis von Hyaluronsäure
IL101056A (en) * 1992-02-24 1997-03-18 Res & Dev Co Ltd Composition for nasal treatment
WO1994010987A1 (en) * 1992-11-09 1994-05-26 Pharmetrix Corporation Combined analgesic delivery methods for pain management
JPH09309843A (ja) * 1996-05-21 1997-12-02 Shiseido Co Ltd ヒアルロン酸含有経肺投与用製剤
JP3634112B2 (ja) * 1997-03-31 2005-03-30 株式会社資生堂 皮膚外用剤
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
EP1019023B1 (en) * 1997-09-29 2003-05-07 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in nebulizers
US6017545A (en) 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
CA2332455C (en) 1998-06-01 2012-08-14 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants

Also Published As

Publication number Publication date
DE50115451D1 (de) 2010-06-02
CY1110906T1 (el) 2015-06-10
WO2002051380A1 (de) 2002-07-04
ATE464878T1 (de) 2010-05-15
DE10064219A1 (de) 2002-07-11
ES2344730T3 (es) 2010-09-06
DE10064219B9 (de) 2009-02-12
DE10064219B4 (de) 2006-10-12
EP1957037A1 (de) 2008-08-20
EP1957037B1 (de) 2010-04-21
PT1957037E (pt) 2010-07-15

Similar Documents

Publication Publication Date Title
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
DK1787639T3 (da) Stabile farmaceutiske formuleringer til tryksamme dosisinhalatorer
CY1105120T1 (el) Η αντιμετωπιση αναπνευστικων νοσων
DK0991407T3 (da) Stabilisering af syresensitive benzimidazoler med amino/cyclodextrin-kombinationer
DE60224284D1 (de) Stabile formulierung von modifiziertem glp-1
CY1113003T1 (el) Ευσταθη παρασκευασματα laquinimod
ATE302616T1 (de) Oral anzuwendende arzneizusammensetzungen mit gesteuerter wirkstoffabgabe
ATE513541T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung von calcitonin
ATE289640T1 (de) Amidofunktionelle aminopolydiorganosiloxane
NO20011721D0 (no) N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor
DK1307227T3 (da) Farmaceutiske sammensætninger
AR030829A1 (es) Una formulacion de vacuna, procedimiento para la produccion de la misma, uso de dicha preparacion y un estuche para su administracion via intranasal
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
SE0101932D0 (sv) Pharmaceutical combinations
EE200100104A (et) 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
MXPA03010054A (es) Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos.
NO20024194L (no) Nytt selvemulgerende legemiddelavleveringssystem
DK1771155T3 (da) Fremgangsmåde og sammensætning til behandling af rhinitis
IT1319210B1 (it) Pellicola per la somministrazione dermica e transdermica di principiattivi.
EE200300192A (et) Guanidiini ja amidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline preparaatning eelravim
DK1150704T3 (da) Melagatran til behandling af betændelse
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
YU87501A (sh) Farmaceutski kompleksi
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar